Education
About Us
Working with TipRanks
Follow Us
Resonance Health Ltd (AU:RHT)
ASX:RHT
Total Valuation
Resonance Health Ltd has a market cap or net worth of AU$18.61M. The enterprise value is AU$21.12M.
Market CapAU$18.61M
Enterprise ValueAU$21.12M
Share Statistics
Resonance Health Ltd has 477,120,240 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding477,120,240
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Resonance Health Ltd’s return on equity (ROE) is -0.18 and return on invested capital (ROIC) is -14.62%.
Return on Equity (ROE)-0.18
Return on Assets (ROA)-0.10
Return on Invested Capital (ROIC)-14.62%
Return on Capital Employed (ROCE)-0.15
Revenue Per Employee615.17K
Profits Per Employee-96.27K
Employee Count18
Asset Turnover0.62
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Resonance Health Ltd is 4.0. Resonance Health Ltd’s PEG ratio is 0.00976.
PE Ratio4.0
PS Ratio1.60
PB Ratio1.89
Price to Fair Value1.89
Price to FCF22.05
Price to Operating Cash Flow43.86
PEG Ratio0.00976
Income Statement
In the last 12 months, Resonance Health Ltd had revenue of 11.07M and earned -1.73M in profits. Earnings per share was 0.00.
Revenue11.07M
Gross Profit11.07M
Operating Income-1.93M
Pretax Income-2.20M
Net Income-1.73M
EBITDA-1.41M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 420.56K and capital expenditures -373.65K, giving a free cash flow of 46.91K billion.
Operating Cash Flow420.56K
Free Cash Flow46.91K
Free Cash Flow per Share<0.01
Dividends & Yields
Resonance Health Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.39
52-Week Price Change-7.14%
50-Day Moving Average0.04
200-Day Moving Average0.04
Relative Strength Index (RSI)45.27
Average Volume (3m)274.25K
Important Dates
Resonance Health Ltd upcoming earnings date is Aug 28, 2026, TBA (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateAug 28, 2026
Ex-Dividend Date―
Financial Position
Resonance Health Ltd as a current ratio of 1.28, with Debt / Equity ratio of 47.52%
Current Ratio1.28
Quick Ratio1.28
Debt to Market Cap0.16
Net Debt to EBITDA-0.59
Interest Coverage Ratio-6.05
Taxes
In the past 12 months, Resonance Health Ltd has paid 465.93K in taxes.
Income Tax465.93K
Effective Tax Rate-0.21
Enterprise Valuation
Resonance Health Ltd EV to EBITDA ratio is -13.20, with an EV/FCF ratio of 23.07.
EV to Sales1.68
EV to EBITDA-13.20
EV to Free Cash Flow23.07
EV to Operating Cash Flow14.88
Balance Sheet
Resonance Health Ltd has AU$2.69M in cash and marketable securities with AU$5.20M in debt, giving a net cash position of -AU$2.51M billion.
Cash & Marketable SecuritiesAU$2.69M
Total DebtAU$5.20M
Net Cash-AU$2.51M
Net Cash Per Share>-AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 96.54%, with operating margin of -17.42%, and net profit margin of -15.65%.
Gross Margin96.54%
Operating Margin-17.42%
Pretax Margin-19.86%
Net Profit Margin-15.65%
EBITDA Margin-12.72%
EBIT Margin-14.30%
Analyst Forecast
The average price target for Resonance Health Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast28.91%
EPS Growth Forecast-1050.00%